Home > Press > MO-SCI Corporation to manufacture, market SRNL's unique glass microspheres
Abstract:
Porous walled hollow glass microspheres have applications in energy, medicine, other fields
A licensing agreement between the U.S. Department of Energy's Savannah River National Laboratory (SRNL) and specialty glass provider Mo-Sci Corporation will make SRNL's unique Porous Walled Hollow Glass Microspheres available for use in targeted drug delivery, hydrogen storage and other uses, including applications still being developed.
Hollow glass microspheres have been used for years in light-weight filler material, insulation, abrasives and other uses. What makes SRNL's patent-pending microspheres unique is the network of interconnected pores in the microsphere walls, which allow the tiny "microballoons" to be filled with, hold, and release gases and other materials. Each porous walled hollow glass microsphere is about 50 microns in diameter, about half the width of a human hair. Its walls, which are about 10,000 angstroms thick (an angstrom is one-tenth of one-billionth of a meter) feature pores that range from 100 to 300 angstroms, which allow gases to enter the tiny spheres and be stored or cycled on absorbents inside.
SRNL originally developed the unique microspheres as a solid-state storage method for hydrogen; they have been successfully demonstrated to store and release the gas.
Work since then has shown potential in other uses, including battery applications and medicine. An article by authors from the Medical College of Georgia and SRNL, which has been accepted for publication in the peer-reviewed journal Nanomedicine: Nanotechnology, Biology and Medicine, discusses a possible application for the delivery of anti-cancer drugs. (Porous-wall hollow glass microspheres as novel potential nanocarriers for biomedical applications; Shuyi Li, Lynsa Nguyen, Hairong Xiong, Meiyao Wang, Tom C.-C. Hu, Jin-Xiong She, Steven M. Serkiz, George G. Wicks, William S. Dynan; article in press)
Under the license agreement, Mo-Sci will provide SRNL with a cost-effective supply of the microspheres to continue research and development of additional applications. It also provides for aggressive marketing by Mo-Sci to be the premier supplier for medical R&D applications.
####
About Savannah River National Laboratory
SRNL has long been recognized for its expertise in the science and engineering of glass. The laboratory developed the flowsheets and methods used in the Savannah River Site's facility for converting high-level radioactive waste into a stable glass form.
SRNL is DOE's applied research and development national laboratory at the Savannah River Site (SRS). SRNL puts science to work to support DOE and the nation in the areas of environmental management, national and homeland security, and energy security. The management and operating contractor for SRS and SRNL is Savannah River Nuclear Solutions, LLC.
Mo-Sci Corporation
Mo-Sci Corporation, a small business entity located in Rolla, Missouri, has been producing specialty glass materials since 1985. They currently produce glass materials to serve a variety of markets ranging from pharmaceutical to health care to space travel and automotive components.
Contacts:
Angeline French
803-725-2854
Copyright © Eurekalert
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Energy
KAIST researchers introduce new and improved, next-generation perovskite solar cell November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Development of zinc oxide nanopagoda array photoelectrode: photoelectrochemical water-splitting hydrogen production January 12th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||